v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Before Income Taxes

The loss before income taxes consists of the following US and Israeli components:

 

       
   For The Years Ended 
   December 31, 
   2024   2023 
         
United States  $(4,121,246)  $(4,704,333)
Israel   (391,396)   (616,879)
Loss before income taxes  $(4,512,642)  $(5,321,212)
Schedule of Component of Income Tax Expenses (Benefit)

The provision for income taxes consists of the following expenses (benefits):

 

       
   For The Years Ended 
   December 31, 
   2024   2023 
Deferred          
Federal   (787,495)   (853,959)
Foreign   11,665    (70,906)
U.S. State and local   (487,497)   (554,250)
Total Deferred   (1,263,327)   (1,479,115)
Change in valuation allowance   1,263,327    1,479,115 
Provision for income taxes  $-   $- 
Schedule of Effective Income Tax Rate Reconciliation

The provision for income taxes differs from the United States federal statutory rate as follows:

 

       
   For The Years Ended 
   December 31, 
   2024   2023 
         
Tax benefit at the federal statutory rate   (21.0)%   (21.0)%
State and local taxes, net of federal benefit   (11.9)%   (11.5)%
Statutory rate differential - domestic versus foreign   (0.2)%   (0.2)%
Permanent differences   2.8%   3.9%
Prior period true-up and other   2.2%   1.0%
Change in valuation allowance   28.0%   27.8%
           
Effective income tax rate   0.0%   0.0%
Schedule of Deferred Tax Assets

The tax effects of temporary differences that give rise to deferred tax assets and liabilities are presented below:

 

       
   December 31, 
   2024   2023 
         
Net operating loss carryforwards  $10,753,257   $9,997,830 
Stock-based compensation   612,808    604,164 
Accrued expenses   379,270    208,283 
Deferred research and development expenses   1,268,013    939,744 
Deferred tax assets   13,013,348    11,750,021 
Valuation allowance   (13,013,348)   (11,750,021)
Deferred tax assets, net  $-   $-